FierceBiotech

The Alliance for Regenerative Medicine Elects Geoff MacKay as Next Chair, Welcomes New Officers and Executive Committee

WASHINGTON, DC -- (Marketwire) -- 11/15/12 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine community, announces the election of ...
Business Wire

Industry leader Geoff Mackay to Chair board of Satellos Bioscience

TORONTO--(BUSINESS WIRE)--Drug development start-up Satellos Bioscience has announced that regenerative medicine industry leader Geoff Mackay is joining its board of directors as Chair, effective ...
The Business Journals

MHT All-Star: Geoff MacKay

Title: President, CEO, Organogenesis Inc. Education: Bachelor’s degree, McGill University Geoffrey MacKay joined Organogenesis in 2003 after spending 11 years with Novartis, serving in a variety of ...
The Business Journals

Novartis execs come in as new CEO, VP of sales at Organogenesis

Organogenesis Inc. of Canton continues its recovery with the announcement that it has named Geoff MacKay as its new chief executive officer and Santino Costanzo as its new vice president of sales.
The Wall Street Transcript

Fabry Disease, Gaucher Disease, Pompe Disease and Cystinosis: AVROBIO has One Gene Therapy Platform to Treat them All

Geoff MacKay is President and Chief Executive Officer of AVROBIO, Inc. Mr. MacKay is an experienced CEO with proven success leading innovative businesses. While CEO of Organogenesis Inc., the company ...